decent quarter mostli healthi outlook
reflect valuat
decent quarter mostli outlook reiter neutral
report adjust ep ep beat consensus/our
estim lower tax rate higher-than-expect revenu mostli
off-set higher adjust expens in-lin adjust non-oper incom given
result guidanc outlook rais ep
po vs multipl stronger growth overal
good quarter despit healthi non-transact organ growth given elev
leverag one-tim expens fair valuat reiter neutral rate
mt fundament strong improv enter
mt segment outperform expect drove revenu beat
although much out-performance due episod chang request fee
howev enter fundament seem strong improv annual
recur revenu y/i manag sign new global bank
execut servic bank total sign extended/expand exist
marketplac client announc partnership skytra subsidiari
airbu provid marketplac solut potenti travel index eventu
futur move forward team focus go-to-market approach
manag servic saa softwar servic based-solut overal goal
scale busi deliv improv profit
organ growth decent fy expens guid
expect posit mid-single-digit revenu growth transact non-
transact vs driven continu strength non-transact revenu
segment although expect normal mt given strong non-recur
revenu coupl growth transact rev weaker
expect normal volume enter us elect year expect expens
rise line manag new adj op expens guidanc
lead bp margin expans adj oper margin
expect tax rate line guidanc core non-op expens
moder lower lower interest expens given team within target
leverag rang expect manag focu cash flow dividend growth
invest buyback episod strateg
bofa secur seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
invest
nasdaq omx group found
lead diversifi global exchang offer
trade clear servic market data
product technolog product servic
financi index product list servic public
compani servic compani own
oper market clearinghous
central secur depositori across
europ list compani
global grown year
organ via acquisit
given improv organ growth outlook
came sooner expect yet limit margin
expans elev leverag potenti
area regulatori chang believ
share trade in-lin group
po base pe multipl discount sector
premium recent histor averag given increas portion recur
upsid risk po weak macro backdrop reduc competit less price
pressur margin technolog oper accret regulatori legal
downsid risk po lower volum outlook higher price pressur lower non-
transact revenu lower margin failur opportun
michael carrier cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
new york mellon
qualiti earn
